GlaxoSmithKline's Directors Remuneration Report Passed with Low Vote Count
May 04 2022 - 12:43PM
Dow Jones News
By Sabela Ojea
GlaxoSmithKline PLC said Wednesday that the resolution to
approve its directors' remuneration report passed at its general
meeting with a low vote count, noting that it will continue
explaining the rationale for the changes to shareholders.
The British pharma major said that the resolution only got the
support of 61.76% of the vote count.
"The company undertook an in-depth consultation process with the
majority of its largest shareholders in developing the revised
policy and will continue to engage to ensure it fully understands
the views of all shareholders on these matters," the FTSE 100
listed company said.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
May 04, 2022 13:28 ET (17:28 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
GSK (NYSE:GSK)
Historical Stock Chart
From May 2023 to May 2024